BIO-Europe Spring

The meeting combines a busy conference programme with high-volume 1:1 partnering, creating an efficient environment for business development discussions between biotech innovators, pharma partnering teams, investors and enabling solution providers.

Who the audience is and how many attend

Audience

• Biotech and pharma business development and partnering teams
• Senior executives from emerging and established life sciences companies
• Investors and financial partners active in biotech
• Service providers and ecosystem partners supporting dealmaking

Scale

• Executives attending: 3,700+
• Partnering: 1:1 meetings scheduled via a dedicated partnering system

What to expect

• Three days of partnering-led networking with a strong focus on dealmaking and collaboration
• A packed 1:1 meeting schedule designed to help attendees identify and connect with relevant partners
• A conference programme and receptions designed to support relationship-building across the biotech ecosystem